Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-18

Clinical Trial Update: Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two chlorhexidine digluconate mouthwash formulations (0.12% and 0.03%) for effects on dental plaque and safety; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine digluconate 0.03% mouthwash (chlorhexidine digluconate 0.03% mouthwash)
  • Chlorhexidine digluconate 0.12% mouthwash (Chlorhexidine digluconate)

Snippet

Sponsor: Universitat Internacional de Catalunya | Conditions: Dental Plaque, Side Effects | Phase 2 | Status: COMPLETED